Últimas noticias sobre Elicio Therapeutics (NASDAQ:ELTX) Bolsa

Elicio Therapeutics

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

ALVO

BBGI

BCAX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Elicio Therapeutics Inc

707 Cayman Holdings Shares Resume Trade

Barclays analyst Julian Mitchell maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Equal-Weight and raises the price target from $306 to $323.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Eaton Corp, Raises Price Target to $323

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09115422/Cango-shareholders-0609-900x600-1.png" alt="" class="wp-image-14105" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09115422/Cango-shareholders-0609-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09115422/Cango-shareholders-0609-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09115422/Cango-shareholders-0609-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The company will be controlled by two asset managers tied to Singapore's Antalpha Ventures, while Cango's co-founders' voting rights will drop to 18.54%
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Enduring Wealth, a company tied to Singapore's Antalpha Ventures, will hold a controlling 36.74% of Cango's voting rights after the company's transformation to a bitcoin miner</li>
<li>Cango co-founders Zhang Xiaojun and Lin Jiayuan will see their voting rights in Cango drop to a combined 12.07% post-transformation, from a previous 92.5%</li>
</ul>
After more than a half year of nonstop metamorphosis, a picture is finally starting to emerge of who will be calling the shots at a newly minted&nbsp;Cango Inc.&nbsp;(CANG.US), a former Chinese car trader that has morphed into a global bitcoin miner at remarkable speed.
The company's new shareholding structure was contained in a&nbsp;<a href="https://www.prnewswire.com/news-releases/cango-inc-announces-third-amendment-to-share-settled-crypto-mining-assets-acquisitions-302473085.html">new announcement</a>&nbsp;last week detailing the latest developments in its transformation. The new Cango will be controlled by a larger and more diverse group of shareholders than the earlier one, as the company adds a new cast of backers with strong backgrounds in the finance, asset management and cryptocurrency sectors.&nbsp;
In its previous form as auto financier and later a car trader, Cango co-founders Zhang Xiaojun and Lin Jiayuan were clearly in control of the company, the former as chairman and the latter as CEO. The pair collectively held 45% of Cango's shares and 92.5% of its voting power, according to the company's latest annual report.
The company's new cast, following a series of major reshuffles, is led by&nbsp;Enduring Wealth Capital Ltd., a Singaporean company whose two key decision makers are Andrea Dal Mas and Yu Peng, and which is tied to Singaporean firm&nbsp;Antalpha Ventures. Another major new stakeholder is&nbsp;Golden TechGen Ltd., which is controlled by three people, Wang Ning, Youngil Kim&nbsp;and Wye&nbsp;Sheng Kong. The original co-founders Zhang and Lin will continue to be major stakeholders as well, though they have yielded their control of the company.
The company's final shareholder structure is still contingent on a deal in progress that would see Cango acquire $144 million worth of bitcoin mining machines with 18 EH of capacity from a group of companies led by Golden TechGen, which would bring Cango's total mining capacity to 50 EH. That deal is expected to close by the end of July.
If all goes according to plan, Enduring Wealth will end up with 2.82% of Cango's shares, but a much larger 36.74% of its voting rights, giving it control of the company. Co-founders Zhang and Lin would see their combined holdings drop to 18.54% of the company's shares and 12.07% of its voting power. Golden GenTech would hold 18.79% of the new Cango's shares, and 12.23% of its voting power.
The new shares Cango will issue to Enduring Wealth and the Golden GenTech-led group supplying the 18 EH of additional mining capacity are subject to a six-month lockup period after the deal closes.
As Enduring Wealth's two key decision makers, Andrea Dal Mas and Yu Peng look set to carry the biggest voices in Cango's future direction and strategic decisions. Dal Mas' LinkedIn profile describes him as an Antalpha managing partner, "where he focuses on strategic investments in blockchain technology and artificial intelligence companies." Cango described Yu as "a seasoned and accomplished finance professional with extensive experience in investment management and asset management." Yu was also described as Antalpha's chief strategy officer in an August 2024 announcement from virtual asset manager Pando.
Golden GenTech's Wang Ning is described in Cango's latest announcement as a certified public accountant with more than 16 years of experience in equities, fixed-income and digital-asset markets. Golden GenTech's Youngil Kim&nbsp;is described as having "extensive experience in fintech, strategic planning, and business development, particularly in the&nbsp;crypto&nbsp;and blockchain industry," while Wye&nbsp;Sheng Kong&nbsp;has "rich experience in treasury management, wealth planning, banking operations and financial advisory services."
<h4 class="wp-block-heading">New board</h4>
The latest announcement detailing Cango's new shareholding comes just a week after a new board also began to take shape at the company. Cango was founded about a decade ago and rose to prominence as a car financier, before withdrawing from that business after China cracked down on private fintech firms. It later moved into auto trading services, but last year also sharply slowed its movement in that direction as China's car market faced a major slowdown and huge overcapacity after years of breakneck growth.
It disclosed its bitcoin mining pivot last November by announcing that it had paid $256 million in cash for mining machines with 32 EH of capacity, and planned to acquire machines with another 18 EH of capacity from Golden GenTech in exchange for Cango shares. That second deal is still pending, and Cango said last month it expects it to close by the end of July.
Enduring Wealth gained its controlling stake in Cango as part of a deal announced in March. That deal closed last month after a key condition was met, which saw Cango sell its original China business, including its car-trading business, to Ursalpha Digital Ltd for $352 million in cash, consisting of $211 million up front and the remainder in installments.That deal, which left the company's recently launched car-export business with Cango, could pave the way for the company to relocate its headquarters from Mainland China to a different location like Singapore, Hong Kong or the U.S. Bitcoin mining is currently banned in Mainland China, though all of Cango's mining operations are located outside the country.
Following all those changes, Cango last month also announced a major overhaul of its board, including the departure of four of its seven members. Co-founders Zhang and Lin remained on the board, and were joined by two new directors, Lin Yanjun and Lu Haitian, who both have strong financial backgrounds. Lin Yuanjun is a founding partner of I.N Capital, a blockchain and AI investment and consulting company, while Lu Haitian is a Hong Kong-based accounting and finance professor with expertise in financial, regulatory and sustainability technology.
Those arrivals left Cango with five members on its board. As part of its deal to acquire the 18 EH of mining machines from Golden TechGen last year, Cango said that Golden TechGen's owner at that time, Max Hua, would have the right to name up to two directors to Cango's board. In the latest announcement, the company said that Hua later left Golden TechGen, which is now one-third controlled each by Wang Ning, Youngil Kim and Wye&nbsp;Sheng Kong. Cango said Max Hua's right to name two directors to its board will go to Wang Ning after the transfer of the 18 EH of mining machines closes.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Opinion

Who Will Be Calling The Shots At Newly-Minted Cango?

Barclays analyst Brian Morton maintains Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) with a Underweight and raises the price target from C$90 to C$94.

TSX:CM

Barclays Maintains Underweight on Canadian Imperial Bank, Raises Price Target to C$94

707 Cayman Holdings Shares Open For Trade, Then Halt On Circuit Breaker To The Upside At $4.38/Share

Barclays analyst Tom O'Malley maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Overweight and raises the price target from $215 to $265.

AVGO

Barclays Maintains Overweight on Broadcom, Raises Price Target to $265

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Redburn Atlantic raised Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) price target from $40 to $48. Redburn Atlantic analyst Charles Bendit downgraded the stock from Neutral to Sell. Robinhood shares closed at $74.88 on Friday. <a href="https://www.benzinga.com/quote/HOOD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Redburn Atlantic raised the price target for The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) from $65 to $82. Redburn Atlantic analyst Charles Bendit upgraded the stock from Sell to Neutral. Charles Schwab shares closed at $88.22 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/SCHW/analyst-ratings">view this stock</a>.</li>
<li>Jefferies raised Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) price target from $190 to $200. Jefferies analyst Brent Thill maintained a Buy rating. Oracle shares closed at $174.00 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings">view this stock</a>.</li>
<li>RBC Capital raised the price target for Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) from $215 to $240. RBC Capital analyst Ashish Sabadra maintained a Sector Perform rating. Cintas shares closed at $227.66 on Friday. <a href="https://www.benzinga.com/quote/CTAS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson cut the price target for The Toro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) from $80 to $76. DA Davidson analyst Michael Shlisky maintained a Neutral rating. Toro shares closed at $68.50 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/TTC/analyst-ratings">view this stock</a>.</li>
<li>Compass Point raised Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) price target from $10 to $13. Compass Point analyst Joe Flynn downgraded the stock from Buy to Neutral. Applied Digital shares settled at $13.86 on Friday. <a href="https://www.benzinga.com/quote/APLD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CIBC raised Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) price target from $110 to $125. CIBC analyst Todd Coupland maintained an Outperformer rating. Rubrik shares closed at $97.98 on Friday. <a href="https://www.benzinga.com/quote/RBRK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities boosted Zscaler, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) price target from $285 to $340. B of A Securities analyst Tal Liani maintained a Buy rating. Zscaler shares closed at $303.03 on Friday.  <a href="https://www.benzinga.com/quote/ZS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital increased the price target for Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) from $102 to $103. RBC Capital analyst Steven Shemesh maintained an Outperform rating. Walmart shares settled at $97.43 on Friday. <a href="https://www.benzinga.com/quote/WMT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs slashed General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) price target from $68 to $58. Goldman Sachs analyst James Yaro downgraded the stock from Buy to Neutral. General Mills shares closed at $54.76 on Friday. <a href="https://www.benzinga.com/quote/GIS/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ORCL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ORCL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="605" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09120201/image-120-1024x605.png" alt="" class="wp-image-943486" style="width:675px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09120201/image-120-1024x605.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09120201/image-120-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09120201/image-120-768x454.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09120201/image-120.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45811726/cramer-says-hes-not-going-to-really-want-to-do-a-lot-of-china-right-now">Cramer Says He&#8217;s &#8216;Not Going To Really Want To Do A Lot Of China Right Now&#8217;</a> </li>
</ul>
Photo via Shutterstock

APLD

CTAS

HOOD

ORCL

RBRK

SCHW

Oracle To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/06/2025-06-09_08h54_09.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">China Hopium</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-us-china-trade-talks-apple-wwdc-spy-mc-06092025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul class="wp-block-list">
<li>The chart shows the stock market is approaching the low band of zone 1 (resistance).</li>
<li>Zone 1 is the magnet for traders.</li>
<li>US China trade talks are continuing in London today.&nbsp; President Trump said the talks are very far advanced.</li>
<li>The momo crowd is aggressively buying stocks on hopium about China trade talks, the attraction of the zone 1 magnet, and the weekend pump.&nbsp; Retail investors are especially vulnerable to the weekend pump and buy on Monday mornings.</li>
<li>Prudent investors will be closely watching Treasury auctions this week as 30-year Treasury yields are near 5%.&nbsp; Demand was weak at the previous 20-year Treasury auction.</li>
<li>This morning, yields are rising.</li>
<li>President Trump is thinking about the next Fed Chair and the name of the next Fed Chair nominee is coming out very soon, according to President Trump.</li>
<li>President Trump wants Fed Chair Powell to cut interest rates by 100 basis points.</li>
<li>Even though the momo crowd is oblivious, prudent investors should pay attention to rising yields, pressure by President Trump on Fed Chair Powell, and Treasury auctions.&nbsp; Learning to interpret Treasury auctions can give investors an edge.</li>
<li>Apple Inc.&#8217;s (AAPL) Worldwide Developers Conference (WWDC) starts today.  Apple has been lagging behind in AI and has yet to deliver many of the Apple Intelligence features hyped at WWDC last year.  Investors are not expecting big news at WWDC this week. 
<ul class="wp-block-list">
<li>Developers are hoping for news about Apple's on-device, small AI models that would be faster than current cloud based AI models.&nbsp; However, the useful applications at this point will likely be limited as the on-device models are not yet sufficiently powerful.</li>
<li>Investors may remember how Apple extremely aggressively bought its own stock when AAPL stock fell on disappointment over the last WWDC.&nbsp; Apple's own buying produced a major run in AAPL stock.&nbsp; Will Apple do a repeat this year?</li>
</ul>
</li>
<li>Silver has broken out.  As full disclosure, there are nice profits on Silver ETF iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>) in our ZYX Buy Core Model Portfolio.  A new signal may be given on silver for a trade around position.  Trade around positions are a billionaire and hedge fund technique to increase returns while dramatically reducing risks.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Amazon.com, Inc. (AMZN), NVIDIA Corp (NVDA), Alphabet Inc Class C (GOOG), and Apple (AAPL).
In the early trade, money flows are neutral in Meta Platforms Inc (META).
In the early trade, money flows are negative in Microsoft Corp (MSFT) and Tesla Inc (TSLA).
In the early trade, money flows are positive in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is seeing buying.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Long Ideas

Market Summary

Broad U.S. Equity ETFs

$BTC

Momo Crowd Buys Stocks On China Hopium And Zone 1 Magnet Ignoring Rise In Yields; Silver Breaks Out

Barclays analyst Ramsey El-Assal maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) with a Overweight and raises the price target from $57 to $75.

Barclays Maintains Overweight on Block, Raises Price Target to $75

Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) will focus on advancing innovation, partnerships and collaboration at the 2025 Paris Air Show.
"We continue to make fundamental changes across Boeing to strengthen safety, quality and our culture, and we are seeing steady improvement in our performance," said Boeing President and CEO Kelly Ortberg. "We look forward to connecting with our customers and partners at Le Bourget to demonstrate the work underway to restore trust and move Boeing forward."
Boeing will exhibit various commercial and defense capabilities, autonomous technologies and comprehensive services. The static displays will feature customer commercial jets and defense fixed- and rotary-wing aircraft.
 &nbsp;

Global

Boeing Will Focus On Advancing Innovation, Partnerships And Collaboration At The 2025 Paris Air Show; Co Will Exhibit Various Commercial And Defense Capabilities, Autonomous Technologies And Comprehensive Services

Shares of Klotho Neurosciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) skyrocketed over 680% to $1.60 during Monday morning trading after the company <a href="https://www.benzinga.com/pressreleases/25/06/n45832973/klotho-neuroscience-inc-announces-an-approach-to-increase-longevity-and-healthy-life-span-replace-">highlighted</a> promising pre-clinical study findings for its anti-aging therapy.
What To Know: The biogenetics firm announced that elevating the expression of the Klotho gene could potentially reduce age-related degeneration across multiple organs, thereby increasing both lifespan and health span.
This <a href="https://www.benzinga.com/pressreleases/25/06/n45832973/klotho-neuroscience-inc-announces-an-approach-to-increase-longevity-and-healthy-life-span-replace-">announcement</a> draws on research published in the February 2025 edition of Molecular Therapy. The study demonstrated that a secreted form of the Klotho protein (s-KL), when administered via an AAV9 vector, led to a 20% increase in the lifespan of mice.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45838546/gamestop-gme-stock-volatile-ahead-of-earnings-boosted-by-bitcoin-bet-and-switch-2-hype">GameStop Stock Volatile Ahead Of Earnings, Boosted By Bitcoin Bet And Switch 2 Hype</a>
These findings bolster the therapeutic potential of s-KL in combating age-associated conditions like cognitive decline and neuroinflammation.
Klotho Neurosciences holds an exclusive worldwide license for this s-KL technology from Universitat Autònoma de Barcelona and Institució Catalana de Recerca i Estudis Avançats. 
CEO Dr. Joseph Sinkule stated, &#8220;This recently published paper provides further credence to our development of s-KL as a treatment to reduce age-associated degeneration.&#8221; 
The company is particularly focused on applying this research to neurodegenerative diseases such as ALS, Alzheimer&#8217;s, and Parkinson&#8217;s, with the original discoverer of the Klotho gene, Professor Makoto Kuro-O, serving as a scientific advisor.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45838270/robinhood-stock-is-falling-monday-whats-going-on">Robinhood Stock Is Falling Monday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy KLTO Stock</h2>
By now you're likely curious about how to participate in the market for Klotho Neurosciences &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KLTO has a 52-week high of $5.11 and a 52-week low of $0.12.
Image: Shutterstock

KLTO

Klotho Neurosciences (KLTO) Stock Surges Over 680%: What's Going On?

Donald Trump&#8216;s tariffs on steel and aluminum are likely to have a deep impact on the input costs of the U.S. automaker Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), explains Alex Tsepaev, the chief strategy officer at B2PRIME Group.
What Happened: Unlike globalized automakers like Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), Ford remains deeply tied to U.S.-centric manufacturing, Tsepaev told <a href="http://pro.benzinga.com">Benzinga</a>, suggesting that &#8220;A 50% tariff could inflate COGS significantly just as pricing power erodes in both EV and ICE segments.&#8221;
The cost of goods sold, or COGS, refers to the input costs paid by the firm to manufacture its final products.
Thus, according to Tsepaev, &#8220;Trump's call to double steel tariffs hits straight on Ford's core. Steel makes up more than half of the weight of a vehicle, and Ford can't do anything with this reality. In 2018, similar tariffs were estimated to cost Ford over $1 billion annually. When your business runs on metal and tariffs make the metal more expensive, Wall Street notices it.&#8221;
Earlier in May, Ford <a href="https://www.benzinga.com/news/earnings/25/05/45208083/ford-stock-hits-the-brakes-after-q1-earnings-suspends-guidance-due-to-tariff-related-uncertainty">suspended its financial guidance</a> during the first quarter results, which included full-year adjusted EBIT and adjusted free cash flow, due to tariff-related uncertainty. According to Tsepaev, this was due to a 65% decline in profits, with revenues falling to $40 billion. 
He forecasts that increased input volatility for Ford could lead to downward revisions.
&#8220;In today's environment, policy uncertainty is the new supply chain risk. For investors, Ford looks exposed, rigid, and margin-constrained in all the wrong places,&#8221; Tsepaev added.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45832125/as-trump-flames-powell-for-holding-back-on-rate-cuts-economists-divided-on-feds-app">As Trump Flames Powell For Holding Back On Rate Cuts, Economists Divided On Fed&#8217;s Approach</a>
Why It Matters: Trump doubled U.S. <a href="https://www.benzinga.com/news/topics/25/05/45708977/trump-doubles-steel-tariffs-to-50-saying-it-will-secure-american-jobs-backs-us-steels-takeover-by-japans-nippon">tariffs on imported steel</a> from 25% to 50% on May 31, which took effect on June 4. 
Trump said he initially considered a 40% tariff but raised it after feedback from industry leaders. &#8220;At 25% they can sorta get over that fence,&#8221; he said, adding, &#8220;At 50% nobody&#8217;s getting over that fence.&#8221;
In 2018, Trump-era tariffs prompted a minor rise in U.S. steel production. However, a 2023 report by the International Trade Commission found that these same tariffs increased costs for downstream industries, leading to a more than $3 billion reduction in output for vehicle, machinery, and tool sectors by 2021, suggesting a net negative economic impact.
Shares of Ford ended 1.58% higher on Friday, and they have risen by 6.32% on a year-to-date basis, but it was down 17.12% over the last year. In premarket on Monday, the stock was up 0.05%.
Benzinga Edge Stock Rankings show that Ford had a strong price trend over the short and medium term, but a weaker price trend over the long term. Its momentum ranking was poor, whereas its value ranking was solid at the 89.33th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="150" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09035628/FORD-EDGE-1024x150.png" alt="" class="wp-image-942792" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09035628/FORD-EDGE-1024x150.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09035628/FORD-EDGE-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09035628/FORD-EDGE-768x113.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09035628/FORD-EDGE.png 1152w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were flat in premarket on Monday. The SPY was up 0.083% at $599.64, while the QQQ advanced 0.011% to $529.98, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45816468/ai-data-centers-are-eating-electricity-and-these-3-energy-stocks-could-be-the-biggest-winners-says-analyst">AI Data Centers Are Eating Electricity — And These 3 Energy Stocks Could Be The Biggest Winners, Says Analyst</a></li>
</ul>
Image via Shutterstock

STLA

Trump's Steel Tariffs 'Hits Straight On Ford's Core:' Analyst Sees Higher Input Costs And Eroding Pricing Power For Tesla Rival

Israeli chip startup Speedata has secured a $44 million Series B round, bringing its total funding to $114 million as it prepares to unveil a next-generation processor that may challenge <a href="https://www.benzinga.com/25/05/45609982/elon-musk-rival-ray-kurzweils-beyond-imagination-lands-100m-deal-as-tesla-nvidia-meta-race-toward-ai-powered-humanoid-robots">Nvidia</a>&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) dominance in <a href="https://www.benzinga.com/m-a/25/06/45789800/amd-acquires-another-company-to-expands-ai-arsenal">AI</a> and big data computing,<a href="https://techcrunch.com/2025/06/03/speedata-a-chip-startup-competing-with-nvidia-raises-a-44m-series-b/"> TechCrunch</a> reports.
The round was led by existing investors, including Walden Catalyst Ventures, 83North, Koch Disruptive Technologies, Pitango First, and Viola Ventures, according to TechCrunch. Strategic backers include Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) CEO Lip-Bu Tan, who also serves as managing partner at Walden Catalyst, and Eyal Waldman, co-founder of Mellanox Technologies.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Wall Street's Missing This AI Surgical Tech — You Don't Have To.<a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution"> Invest from $350.</a></li>
</ul>
<h2 class="wp-block-heading">Custom-Built APU Aims To Replace Racks Of Servers With One Chip</h2>
At the heart of Speedata's innovation is the analytics processing unit, a dedicated chip designed to accelerate data analytics from the silicon level up, TechCrunch reports. Unlike graphics processing units, which were originally designed for graphics and later adapted for data workloads, Speedata's analytics processing unit was engineered solely for analytics performance.
&#8220;Our APU is purpose-built for data processing and a single APU can replace racks of servers, delivering dramatically better performance,&#8221; Speedata CEO Adi Gelvan told TechCrunch. &#8220;We aim at becoming the standard processor for data processing — just as GPUs became the default for AI training, we want APUs to be the default for data analytics across every database and analytics platform,&#8221; he added.
In one pharmaceutical test case, Speedata's APU completed a complex data workload in just 19 minutes, compared to 90 hours using conventional hardware. That represents a 280x speed improvement, highlighting the chip&#8217;s potential to redefine industry benchmarks, TechCrunch says.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
The APU currently supports Apache Spark, with a product roadmap that includes integration across major analytics platforms. According to TechCrunch, Speedata aims to position its APU as the industry standard for processing analytics data, similar to how Nvidia&#8217;s GPUs became essential in AI training.
<h2 class="wp-block-heading">Veteran-Backed Founders Bring Deep Silicon Expertise To Market</h2>
Speedata was founded in 2019 by six engineers, including early researchers of multi-threaded coarse-grained reconfigurable architecture, a breakthrough in programmable chip technology, TechCrunch reports. The founding team collaborated with application-specific integrated circuit specialists to design the chip from the ground up to solve analytics bottlenecks.
Since its last funding round, Speedata has finalized the design and manufacturing of its first APU, moving from prototype simulations to production hardware in late 2024. The company is growing a pipeline of several large enterprise customers, although names have not been disclosed, TechCrunch says.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">First Public APU Reveal Scheduled For Databricks Data &amp; AI Summit</h2>
Speedata plans to showcase its APU publicly for the first time at the Databricks&#8217; Data &amp; AI Summit currently underway, according to TechCrunch.
The startup is now expanding its go-to-market operations and growing its pipeline of enterprise clients eager to transition to faster and more efficient data processing, TechCrunch says. With $114 million in total funding, Speedata enters the race with both the hardware and investor backing to compete on a global scale.
As data workloads continue to grow, Speedata's APU could reshape how businesses process information, potentially giving Nvidia its first serious competitor in data-specific chip architecture.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

INTC

NVDA

Israeli Chip Startup Speedata Raises $44M To Challenge Nvidia's AI Dominance With 280x Faster Analytics Processor

Lululemon Athletica's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NYSE">LULU</a>) short percent of float has fallen 7.92% since its last report. The company recently reported that it has 5.94 million shares sold short, which is 6.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Lululemon Athletica Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749484829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Lululemon Athletica has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Lululemon Athletica's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Lululemon Athletica's peer group average for short interest as a percentage of float is 9.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

LULU

Is Lululemon Athletica Gaining or Losing Market Support?

In the current market session, MetLife Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) share price is at $79.96, after a 0.04% spike. Moreover, over the past month, the stock fell by 2.06%, but in the past year, increased by 15.10%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749484823_0.png" alt="Past Year Chart" />

<h3>How Does MetLife P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
MetLife has a lower P/E than the aggregate P/E of 14.2 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749484823_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: MetLife

Ciena's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) short percent of float has fallen 7.13% since its last report. The company recently reported that it has 3.90 million shares sold short, which is 4.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ciena Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749484824_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ciena has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ciena's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ciena's peer group average for short interest as a percentage of float is 6.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CIEN

Is the Market Bullish or Bearish on Ciena?

Dominion Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) short percent of float has risen 20.74% since its last report. The company recently reported that it has 24.85 million shares sold short, which is 3.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.46 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Dominion Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749484818_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dominion Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Dominion Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Dominion Energy's peer group average for short interest as a percentage of float is 3.35%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Dominion Energy Gaining or Losing Market Support?

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 15 years by 4.82% on an annualized basis producing an average annual return of 16.66%. Currently, W.W. Grainger has a market capitalization of $52.72 billion. 
Buying $100 In GWW: If an investor had bought $100 of GWW stock 15 years ago, it would be worth $1,036.26 today based on a price of $1094.37 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749484816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Barclays analyst Matt Miksic maintains Bausch &amp; Lomb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) with a Equal-Weight and lowers the price target from $19 to $16.

BLCO

Barclays Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16

Deutsche Bank analyst Steve Powers maintains Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) with a Hold and lowers the price target from $38 to $29.

BF/B

Deutsche Bank Maintains Hold on Brown-Forman, Lowers Price Target to $29

Earnings

Press Releases

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Health Care

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

General

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

Financing

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Management

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Elicio Therapeutics Secures $10 Million in Financing

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Atossa Therapeutics

Cabaletta Bio

C4 Therapeutics

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

EXoZymes

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

TuHURA Biosciences

IO Biotech

Invivyd

Korro Bio

Lexeo Therapeutics

Macrogenics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Spero Therapeutics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

TScan Therapeutics

Tenaya Therapeutics

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

HC Wainwright & Co.

Jones Trading

Screenshot 2024-06-07 at 5.22.00 PM

Biotech

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Screenshot 2024-04-10 at 5.39.01 PM

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Screenshot 2024-04-04 at 5.26.54 PM

Unlocking The Power Of Immunotherapy: Elicio Therapeutics&#39; (NASDAQ: ELTX) Novel AMP Platform

Comments

Elicio Therapeutics

Noticias

Últimas noticias sobre Elicio Therapeutics (NASDAQ:ELTX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL